These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27903997)

  • 41. Omega-3 fatty acids supplementation does not affect serum lipids in chronic hemodialysis patients.
    Poulia KA; Panagiotakos DB; Tourlede E; Rezou A; Stamatiadis D; Boletis J; Zampelas A
    J Ren Nutr; 2011 Nov; 21(6):479-84. PubMed ID: 21439849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
    McKenney JM; Sica D
    Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications.
    Viecelli AK; Pascoe E; Polkinghorne KR; Hawley C; Paul-Brent PA; Badve SV; Cass A; Heritier S; Kerr PG; Mori TA; Robertson A; Seong HL; Irish AB;
    BMC Nephrol; 2015 Jun; 16():89. PubMed ID: 26116581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
    Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
    Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of zinc supplementation on triglyceride, cholesterol, LDL, and HDL levels in zinc-deficient hemodialysis patients.
    Roozbeh J; Hedayati P; Sagheb MM; Sharifian M; Hamidian Jahromi A; Shaabani S; Jalaeian H; Raeisjalali GA; Behzadi S
    Ren Fail; 2009; 31(9):798-801. PubMed ID: 19925287
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: a randomized clinical trial.
    Asztalos IB; Gleason JA; Sever S; Gedik R; Asztalos BF; Horvath KV; Dansinger ML; Lamon-Fava S; Schaefer EJ
    Metabolism; 2016 Nov; 65(11):1636-1645. PubMed ID: 27733252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial.
    Samimi M; Jamilian M; Asemi Z; Esmaillzadeh A
    Clin Nutr; 2015 Jun; 34(3):388-93. PubMed ID: 24973862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients.
    An WS; Kim SE; Kim KH; Lee S; Park Y; Kim HJ; Vaziri ND
    J Ren Nutr; 2009 Jul; 19(4):267-74. PubMed ID: 19539181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nutrition-related cardiovascular risk factors in hemodialysis patients.
    Arslan Y; Kiziltan G
    J Ren Nutr; 2010 May; 20(3):185-92. PubMed ID: 19819725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions.
    O'Keefe JH; Abuissa H; Sastre A; Steinhaus DM; Harris WS
    Am J Cardiol; 2006 Apr; 97(8):1127-30. PubMed ID: 16616012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
    Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
    J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Omega-3 fatty acid supplementation on lipid profiles in dialysis patients: meta-analysis.
    Chi H; Lin X; Huang H; Zheng X; Li T; Zou Y
    Arch Med Res; 2014 Aug; 45(6):469-77. PubMed ID: 25010561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial.
    Gharekhani A; Khatami MR; Dashti-Khavidaki S; Razeghi E; Noorbala AA; Hashemi-Nazari SS; Mansournia MA
    Eur J Clin Pharmacol; 2014 Jun; 70(6):655-65. PubMed ID: 24643636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial.
    Scorletti E; West AL; Bhatia L; Hoile SP; McCormick KG; Burdge GC; Lillycrop KA; Clough GF; Calder PC; Byrne CD
    J Hepatol; 2015 Dec; 63(6):1476-83. PubMed ID: 26272871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia.
    Maki KC; Bays HE; Dicklin MR; Johnson SL; Shabbout M
    J Clin Lipidol; 2011; 5(6):483-92. PubMed ID: 22108152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis.
    Olveira G; Olveira C; Acosta E; Espíldora F; Garrido-Sánchez L; García-Escobar E; Rojo-Martínez G; Gonzalo M; Soriguer F
    Arch Bronconeumol; 2010 Feb; 46(2):70-7. PubMed ID: 20045240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of omega-3 on lipid profile and inflammation markers in peritoneal dialysis patients.
    Hassan KS; Hassan SK; Hijazi EG; Khazim KO
    Ren Fail; 2010; 32(9):1031-5. PubMed ID: 20863205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paraoxonase enzyme activity is enhanced by zinc supplementation in hemodialysis patients.
    Rahimi-Ardabili B; Argani H; Ghorbanihaghjo A; Rashtchizadeh N; Naghavi-Behzad M; Ghorashi S; Nezami N
    Ren Fail; 2012; 34(9):1123-8. PubMed ID: 22950600
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study.
    Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H
    Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.